Diazepam Rectal

Contraindicated

Diazepam Rectal Ensitrelvir Increased CYP3A substrates exposure and an increased risk of CYP3A substrates-related adverse effects Details Diazepam Rectal Flumazenil Increased risk of serious adverse effects in patients who are physically dependent on benzodiazepines, including seizures Details Diazepam Rectal Isocarboxazid Marplan An increased risk of CNS depression Details

Major

Diazepam Rectal Abametapir Increased exposure of CYP3A4 substrate Details Diazepam Rectal Acepromazine PROMACE Increased risk of CNS depression Details Diazepam Rectal Alfentanil Increased risk of respiratory or CNS depression and hypotension Details Diazepam Rectal Alprazolam Xanax Increased risk of CNS depression Details Diazepam Rectal Amobarbital Amytal An increased risk of CNS and respiratory depression Details Diazepam Rectal Anileridine Increased risk of profound sedation, respiratory and CNS depression, coma and death Details Diazepam Rectal Apalutamide Erleada Reduced CYP2C19/CYP3A4 substrate exposure Details Diazepam Rectal Aprepitant Aponvie Increased exposure to benzodiazepines and an increased risk of benzodiazepine-related adverse reactions Details Diazepam Rectal Aripiprazole Abilify Increased risk of CNS depression and orthostatic hypotension Details Diazepam Rectal Aripiprazole Lauroxil Aristada Increased risk of CNS depression and orthostatic hypotension Details Diazepam Rectal Asenapine Saphris Increased risk of CNS depression Details Diazepam Rectal Avacopan Tavneos Increased CYP3A4 substrate exposure Details Diazepam Rectal Baclofen Fleqsuvy Increased risk of CNS depression Details Diazepam Rectal Benperidol Increased risk of CNS depression Details Diazepam Rectal Benzhydrocodone Increased risk of respiratory and CNS depression Details Diazepam Rectal Bromazepam Increased risk of respiratory or cardiovascular depression Details Diazepam Rectal Bromopride Potentiation of sedative effects Details Diazepam Rectal Buprenorphine Belbuca An increased risk of CNS depression and respiratory depression Details Diazepam Rectal Buspirone Bucapsol Increased risk of CNS depression Details Diazepam Rectal Butabarbital An increased risk of CNS and respiratory depression Details Diazepam Rectal Butalbital An increased risk of CNS depression Details Diazepam Rectal Butorphanol Butorphic Increased risk of respiratory and CNS depression Details Diazepam Rectal Calcifediol Rayaldee Altered serum levels of calcifediol Details Diazepam Rectal Calcium Oxybate Xywav An increased risk of CNS depression and clinically significant respiratory depression, obtundation, hypotension, profound sedation... Details Diazepam Rectal Cannabidiol Epidiolex Increased CYP2C19 substrate exposure, an increased risk of CYP2C19 substrate-related adverse reactions, an increased risk of CNS d... Details Diazepam Rectal Cannabis An increased risk of CNS depression Details Diazepam Rectal Carbamazepine Carbatrol Reduced diazePAM exposure, reduced diazePAM efficacy and an increased risk of respiratory depression, profound sedation, hypotensi... Details Diazepam Rectal Carbidopa Lodosyn An increased risk of CNS depression Details Diazepam Rectal Carbinoxamine Carbzah An increased risk of CNS depression Details Diazepam Rectal Carisoprodol Soma Additive respiratory depression Details Diazepam Rectal Carphenazine Increased risk of CNS depression Details Diazepam Rectal Cetirizine Aller-Tec Increased risk of CNS depression Details Diazepam Rectal Chloral Hydrate Additive respiratory depression Details Diazepam Rectal Chlordiazepoxide Increased risk of CNS depression Details Diazepam Rectal Chlorpromazine Increased risk of CNS depression Details Diazepam Rectal Chlorzoxazone Lorzone Additive respiratory depression Details Diazepam Rectal Clarithromycin Biaxin Increased exposure of CYP3A4 substrate and risk for toxicity Details